SEARCH
検索詳細
佐野 芳 (サノ カオリ)
| 総合イノベーション創発機構ワクチン研究開発拠点 | 特任講師 |
研究者基本情報
■ 学位■ URL
researchmap URLホームページURL■ ID 各種
J-Global ID■ 研究キーワード・分野
研究キーワード研究分野
経歴
■ 経歴経歴
- 2025年11月 - 現在
北海道大学, ワクチン研究開発拠点, 特任講師 - 2025年04月 - 現在
国立健康危機管理研究機構 国立感染症研究所, インフルエンザ研究センター, 主任研究員 - 2024年04月 - 2025年03月
厚生労働省 国立感染症研究所, インフルエンザ・呼吸器系ウイルス研究センター, 主任研究官 - 2023年01月 - 2024年03月
厚生労働省 国立感染症研究所, インフルエンザ・呼吸器系ウイルス研究センター, 研究員 - 2022年04月 - 2022年12月
公益財団法人東京都医学総合研究所, 疾患制御研究分野, 研究員 - 2021年01月 - 2022年03月
マウントサイナイ医科大学, 微生物学部門, ポストドクトラルフェロー - 2021年01月 - 2022年03月
独立行政法人日本学術振興会, 海外特別研究員 - 2018年06月 - 2020年12月
国立感染症研究所, 感染病理部 第三室, 任期付き研究員 - 2018年04月 - 2018年06月
日本学術振興会, 特別研究員(DC2)
研究活動情報
■ 受賞- 2025年10月, 日本ワクチン学会, 高橋奨励賞
呼吸器ウイルスワクチンにより誘導される分泌型IgA抗体についての研究
佐野 芳 - 2025年09月, 19th Vaccine Congress, Host Country Early Career Researcher Award
Kaori Sano - 2019年10月, 日本ウイルス学会, 第67回日本ウイルス学会学術集会ベストポスター賞
経鼻インフルエンザワクチンで誘導された抗HA stalk抗体のHAおよびNAの立体障害による抗ウイルス効果の発現
佐野 芳 - 2018年11月, 日本ウイルス学会, 第66回日本ウイルス学会学術集会ベストポスター賞
経鼻インフルエンザワクチン接種者由来広域中和抗体のエスケープ変異体ウイルスの解析
佐野 芳 - 2016年11月, 東北大学大学院医学系研究科, 辛酉優秀学生賞
佐野 芳
- A novel candidate vaccine virus derived from Japan's first mammalian case of clade 2.3.4.4b A/H5N1 highly pathogenic avian influenza virus.
Yasushi Suzuki; Tomoko Arita; Masayuki Shirakura; Noriko Kishida; Kaori Sano; Shinji Watanabe; Noriyo Nagata; Yusuke Sakai; Naoko Iwata-Yoshikawa; Tadaki Suzuki; Hideki Hasegawa; Hideki Asanuma
Vaccine, 91, 129048, 129048, 2026年10月03日, [国際誌]
英語, 研究論文(学術雑誌), The development of candidate vaccine viruses (CVVs) for pre-pandemic preparedness requires attenuation of pathogenicity while maintaining immunogenicity. In this study, we developed and characterized NIID-002, a reassortant virus derived from A/Ezo red fox/Hokkaido/1/2022 (H5N1; clade 2.3.4.4b), to evaluate its suitability as a candidate vaccine. NIID-002 exhibited markedly reduced pathogenicity compared with its parental strain, while retaining broad antigenic reactivity and protein yield comparable to other clade 2.3.4.4b CVVs. In mammalian models, NIID-002 demonstrated strong attenuation, causing no lethal infection in mice and only minimal weight loss with limited viral replication in ferrets. Antisera raised against NIID-002 reacted broadly with recent wild-type H5N1 isolates, suggesting potential broad protection. Protein yield analysis confirmed a production efficiency comparable to that of other CVVs within the same clade, supporting its feasibility for large-scale vaccine manufacturing. Overall, NIID-002 fulfills the key requirements for the pandemic preparedness of CVV, combining reduced pathogenicity, broad antigenic reactivity, and adequate production efficiency. These findings highlight its potential as a candidate H5N1 vaccine and underscore the continued need for surveillance and refinement of influenza vaccine strategies to address evolving viral threats. - Anti‐idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes
Hiroshi Itou; Kaori Sano; Akira Ainai; Kazushige Otsuki; Toshikazu Inoue; Takuya Hemmi; Hideki Hasegawa; Tadaki Suzuki
Protein Science, 2026年10月
研究論文(学術雑誌) - Immune response and IgG subclass dynamics following repeated SARS-CoV-2 mRNA vaccination in Japanese healthcare workers.
Kaori Sano; Hideaki Kato; Akihide Ryo; Hideki Hasegawa; Kei Miyakawa
Vaccine, 77, 128396, 128396, 2026年02月26日, [国際誌]
英語, 研究論文(学術雑誌), In Japan, many healthcare workers received up to seven doses of SARS-CoV-2 mRNA vaccines by April 2024. While repeated vaccination aims to strengthen immunity, concerns about immune imprinting and IgG subclass switching, particularly to IgG4, have arisen. This study examined 19 healthcare workers who completed seven doses. Serum and PBMCs collected at five or three time points respectively to measure were analyzed for IgG subclasses, neutralizing antibodies and cellular responses. IgG1-3 levels declined after the second dose but recovered after the third, whereas IgG4 increased post-second dose and remained stable. Neutralizing antibodies against Omicron XBB.1.5 were undetectable after two doses but appeared after the third, despite all being Wuhan strain vaccines, and rose further after the sixth and seventh doses with updated formulations. Cellular immunity remained stable throughout. These findings indicate repeated mRNA vaccination enhances humoral immunity without progressive IgG4 elevation or additional cellular response boosts. - Applications of Pseudoviruses Bearing Glycoproteins of SARS-CoV-2 and Influenza Virus.
Makoto Ota; Kaori Sano; Kenji Yoshihara; Shinji Watanabe; Hideki Hasegawa; Kei Miyakawa
Advances in experimental medicine and biology, 1491, 361, 372, 2026年, [国際誌]
英語, 研究論文(学術雑誌), This review discusses pseudoviruses, which are chimeric viral particles constructed by replacing the envelope glycoproteins of viruses such as human immunodeficiency virus (HIV) or vesicular stomatitis virus (VSV) with those of target viruses, and their advantages in the study of highly pathogenic respiratory viruses. These systems serve as valuable tools for elucidating viral entry mechanisms, screening antiviral drugs, quantitatively assessing virus-neutralizing antibodies, and evaluating vaccine efficacy, while reducing the safety risks associated with live viruses. Despite limitations such as applicability primarily to enveloped viruses, ongoing technological advances continue to improve pseudovirus systems, increasing their utility in vaccine development, antiviral research, and rapid response to emerging infectious diseases. - SARS-CoV-2 spike-specific IgG4 class switching associates with clinical recovery in Long COVID.
Kaori Sano; Yayoi Kimura; Koichi Hirahata; Hideaki Kato; Hideki Hasegawa; Hidenori Akutsu; Akihide Ryo; Atsushi Goto; Kei Miyakawa
The Journal of infection, 91, 5, 106641, 106641, 2025年11月, [国際誌]
英語 - Integrative mapping of preexisting influenza immune landscapes predicts vaccine response.
Stephanie Hao; Ivan Tomic; Benjamin B Lindsey; Ya Jankey Jagne; Katja Hoschler; Adam Meijer; Juan Manuel Carreño Quiroz; Philip Meade; Kaori Sano; Chikondi Peno; André G Costa-Martins; Debby Bogaert; Beate Kampmann; Helder Nakaya; Florian Krammer; Thushan I de Silva; Adriana Tomic
The Journal of clinical investigation, 135, 18, 2025年09月16日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUNDPredicting individual vaccine responses is a substantial public health challenge. We developed Immunaut, an open-source, data-driven framework for systems vaccinologists to analyze and predict immunological outcomes across diverse vaccination settings, beyond traditional assessments.METHODSUsing a comprehensive live attenuated influenza vaccine (LAIV) dataset from 244 Gambian children, Immunaut integrated prevaccination and postvaccination humoral, mucosal, cellular, and transcriptomic data. Through advanced modeling, our framework provided a holistic, systems-level view of LAIV-induced immunity.RESULTSThe analysis identified 3 distinct immunophenotypic profiles driven by baseline immunity: (a) CD8+ T cell responders with strong preexisting immunity boosting memory T cell responses; (b) mucosal responders with prior influenza A virus immunity developing robust mucosal IgA and subsequent influenza B virus seroconversion; and (c) systemic, broad influenza A virus responders starting from immune naivety who mounted broad systemic antibody responses. Pathway analysis revealed how preexisting immune landscapes and baseline features, such as mucosal preparedness and cellular support, quantitatively dictate vaccine outcomes.CONCLUSIONOur findings emphasize the power of integrative, predictive frameworks for advancing precision vaccinology. The Immunaut framework is a valuable resource for deciphering vaccine response heterogeneity and can be applied to optimize immunization strategies across diverse populations and vaccine platforms.FUNDINGWellcome Trust (110058/Z/15/Z); Bill & Melinda Gates Foundation (INV-004222); HIC-Vac Consortium; NIAID (R21 AI151917); NIAID CEIRR Network (75N93021C00045). - Long COVIDにおけるS-IgG4クラススイッチングと症状改善の関連性
宮川 敬; 佐野 芳; 木村 弥生; 平畑 光一; 加藤 英明; 長谷川 秀樹; 梁 明秀; 後藤 温
臨床とウイルス, 53, 3, 189, 189, 日本臨床ウイルス学会, 2025年09月
日本語 - SARS-CoV-2 mRNAワクチンの頻回接種によるIgGサブクラス動態 初期変化とその長期安定性
佐野 芳; 加藤 英明; 梁 明秀; 長谷川 秀樹; 宮川 敬
臨床とウイルス, 53, 3, 234, 234, 日本臨床ウイルス学会, 2025年09月
日本語 - 発光性ウイルス様粒子を用いた高病原性鳥インフルエンザ中和抗体の迅速評価系の開発
太田 真; 佐野 芳; 百瀬 文隆; 岸田 典子; 有田 知子; 鈴木 康司; 白倉 雅之; 浅沼 秀樹; 渡邉 真治; 長谷川 秀樹; 宮川 敬
臨床とウイルス, 53, 3, 237, 237, 日本臨床ウイルス学会, 2025年09月
日本語 - Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC.
Kaori Sano; Kei Miyakawa; Hideaki Kato; Yayoi Kimura; Atsushi Goto; Akihide Ryo; Shinji Watanabe; Hideki Hasegawa
Vaccine, 62, 127472, 127472, 2025年08月30日, [国際誌]
英語, 研究論文(学術雑誌), The emergence of SARS-CoV-2 variants poses ongoing challenges to vaccine efficacy. We evaluated neutralizing antibody responses against JN.1 and its derivatives (KP.3, KP.3.1.1, LB.1, and XEC) in healthcare workers who received seven doses of BNT162b2, including the XBB.1.5 monovalent vaccine. In COVID-19-naïve individuals, KP.3.1.1 and LB.1 showed substantial immune escape, whereas previously infected individuals maintained neutralization activity against all variants. We also demonstrated that JN.1-based immunization induces robust cross-neutralizing activity against emerging variants. A single amino acid deletion at position 31 in the spike protein may be associated with enhanced immune evasion. These findings support the potential effectiveness of JN.1-based vaccines while highlighting the need for continued surveillance and vaccine optimization. - Induction of hemagglutinin stalk reactive antibodies by the administration of a live-attenuated influenza virus vaccine in children.
Juan Manuel Carreño; Philip Meade; Na Fatimata Sogodogo; Kaori Sano; Johnstone Tcheou; Ariel Raskin; Gagandeep Singh; Miriam Fried; Madhumathi Loganathan; Benjamin Francis; Dominika Bielak; Ya Jankey Jagne; Hadijatou J Salah; Florian Krammer; Thushan I de Silva
iScience, 28, 7, 112893, 112893, 2025年07月18日, [国際誌]
英語, 研究論文(学術雑誌), Early life exposures to influenza viruses may imprint a hemagglutinin group-specific signature on immunity that impacts future responses to infection or vaccination. We assessed the administration of a live attenuated influenza virus (LAIV) vaccine in children. Two LAIV formulations (2016-17 and 2017-18) containing distinct H1N1 components were used. Modest boosting of pre-existing serum stalk reactive titers and enhancement of functional antibody-dependent cellular cytotoxicity activity (ADCC) was observed. The magnitude of stalk antibody induction in children naive to influenza A viruses was low; however, LAIV induced de novo stalk antibodies, increasing the number of children seropositive to both group 1 (G1) and group 2 (G2) influenza viruses. The 2018 LAIV formulation, containing an updated H1N1 component, induced higher stalk reactive antibodies with strong ADCC effector functions to the G1 stalk. No significant changes were detected in NA-reactive antibodies in serum or in stalk- or NA-secretory IgA (sIgA) in oral fluid. - Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses.
Kei Miyakawa; Makoto Ota; Kaori Sano; Fumitaka Momose; Noriko Kishida; Tomoko Arita; Yasushi Suzuki; Masayuki Shirakura; Hideki Asanuma; Shinji Watanabe; Hideki Hasegawa
Journal of medical virology, 97, 5, e70394, 2025年05月, [国際誌]
英語, 研究論文(学術雑誌), The recent emergence of the H5N1 influenza virus in dairy cattle has raised significant public health concerns. Using a previously established pseudovirus-based neutralization assay, we evaluated the impact of emerging hemagglutinin (HA) mutations on the efficacy of current candidate vaccine viruses (CVVs). Neutralization analysis revealed that the cow-derived H5N1 virus showed up to a 2.2-fold reduction in sensitivity compared to the CVV homologous neutralization titers. Among the 1,453 HA sequences analyzed from cow-derived H5N1 viruses, we identified four major mutations (E2K, D104G, V147M, and S336N) that emerged after the initial isolation, with 134 isolates (9.22%) harboring all four mutations. These multi-mutation variants exhibited up to a 3.3-fold reduction compared with the CVV homologous neutralization titers. Single-mutation analysis demonstrated that the D104G mutation, present in 47.8% of sequences, markedly contributed to antibody escape. Our findings highlight the importance of continued surveillance and antigenic evaluation of emerging variants for pandemic preparedness strategies. - Humoral and Cell-Mediated Immunity Against SARS-CoV-2 in Healthcare Personnel Who Received Multiple mRNA Vaccines: A 4-Year Observational Study.
Hideaki Kato; Kaori Sano; Kei Miyakawa; Takayuki Kurosawa; Kazuo Horikawa; Yayoi Kimura; Atsushi Goto; Akihide Ryo
Infectious disease reports, 17, 3, 2025年04月29日, [国際誌]
英語, 研究論文(学術雑誌), Background/Objectives: The long-term effects of multiple updated vaccinations against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have not been clarified. Humoral or cellular immunity dynamics in healthcare workers for four years were analyzed. Methods: Blood samples were collected at five time points from April 2021 to January 2024. Humoral immunity was analyzed using the 50% neutralizing titer (NT50) against the original Omicron XBB and Omicron BA.2.86 strains and cellular immunity were analyzed using the ELISpot interferon-gamma releasing assay. NT50s and the spot-forming count (SFC) of the ELISpot assay were compared in the SARS-CoV-2 Omicron XBB-, Omicron-infected, and uninfected subjects. Results: 32 healthcare workers (median age, 47 years) who received 3-7 vaccine doses were enrolled. The NT50s against the original strain decreased after the second vaccination but were maintained after the third vaccine dose. NT50s against the Omicron XBB and BA.2.86 strains were detected before the Omicron vaccine was introduced and increased following the updated vaccination. The NT50s against the Omicron XBB and BA.2.86 strains were elevated after natural infection by the Omicron strain, albeit without differences compared with the findings in uninfected subjects. Multivariate regression analysis revealed no confounder that affected the antibody titer against the BA.2.86 strain at the fifth blood sampling. The median number of SFCs ranged from 78 to 208 after the first two doses. Conclusions: Multiple vaccinations induced the production of antibodies with divergent activity against emerging mutant strains and enhanced protective effects against the original strain. This finding supported the importance of updated vaccination. - Rapid and Safe Neutralization Assay for Circulating H5N1 Influenza Virus in Dairy Cows.
Kei Miyakawa; Makoto Ota; Kaori Sano; Fumitaka Momose; Takashi Okura; Noriko Kishida; Tomoko Arita; Yasushi Suzuki; Masayuki Shirakura; Hideki Asanuma; Shinji Watanabe; Akihide Ryo; Hideki Hasegawa
Influenza and other respiratory viruses, 18, 12, e70048, 2024年12月, [国際誌]
英語, 研究論文(学術雑誌), Rapid and safe neutralization assays are required for highly pathogenic avian influenza viruses, including a clade 2.3.4.4b H5N1 subtype recently found in cows. Here, we report a neutralization assay using luminescent virus-like particles. This assay has lower biosafety requirements and provides a larger dynamic range than conventional methods. We applied this technique to evaluate the cross-reactivity of neutralizing antibodies induced by clade 2.3.4.4b candidate vaccine viruses (CVVs) with the cow-derived H5N1 virus. Our findings indicate that these CVVs share antigenic characteristics with the cow-derived H5N1 virus, suggesting the potential efficacy of vaccines developed using these CVVs. - Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan.
Kaori Sano; Takayuki Kurosawa; Kazuo Horikawa; Yayoi Kimura; Atsushi Goto; Akihide Ryo; Hideki Hasegawa; Hideaki Kato; Kei Miyakawa
Vaccine, 42, 26, 126452, 126452, 2024年10月16日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Up to seven doses of coronavirus disease 2019 (COVID-19) mRNA vaccines (BNT162b2) were administered to Japanese healthcare workers, until February 2024. The monovalent Omicron XBB.1.5 vaccine (hereafter called XBB.1.5 vaccine) was used for dose 7. OBJECTIVE: Although the XBB.1.5 vaccine has been reported to induce a robust increase in neutralizing antibodies against the currently circulating Omicron variant BA.2.86, little is known about its serological effects in Japan, where the BNT162b2 mRNA vaccine is the most frequently administered in the world. STUDY DESIGN: Twenty-five recipients of the XBB.1.5 vaccine, categorized as seronegative (n = 18) or seropositive (n = 7) based on their recent history of COVID-19, were analyzed. Neutralizing antibody titers against Omicron subvariants, receptor binding domain (RBD) IgG levels, IgG subclass distribution, and T-cell responses were assessed. RESULTS: We found a significant increase in neutralizing antibody titers against XBB.1.5 and BA.2.86 variants following XBB.1.5 vaccination, particularly in seropositive individuals. No significant change in total RBD IgG levels was observed, indicating efficient induction of antibodies targeting regions outside the RBD by XBB.1.5 vaccination. IgG subclass analysis demonstrated no significant subclass switching after vaccination. T-cell responses against the virus were comparable between seropositive and seronegative groups. CONCLUSIONS: The study suggests that XBB.1.5 vaccination enhances humoral immunity against Omicron variants without significant IgG subclass switching. However, some individuals with low pre-vaccination IgG titers did not exhibit increased antibody levels post-vaccination, raising concerns about potential immune tolerance. - An ELISA‐Based Method to Measure Mucosal Antibody Responses Against SARS‐CoV‐2 in Human Saliva
Disha Bhavsar; Kaori Sano; Gagandeep Singh; Florian Krammer
Current Protocols, 4, 4, Wiley, 2024年04月05日
研究論文(学術雑誌), Abstract
The primary mode of transmission for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is infection of the respiratory tract through droplets and/or aerosols. Therefore, immune responses at respiratory mucosal surfaces play a significant role in the prevention of infection. Greater emphasis is now being placed on mucosal immunity induced by exposure to SARS‐CoV‐2 antigens through infection or vaccination. In concert with cellular immunity, humoral responses at mucosal surfaces, especially the secretory version of immunoglobulin A (sIgA), can be instrumental in preventing respiratory infections. A better understanding of mucosal immune responses can further our knowledge of immunity to SARS‐CoV‐2 and help inform vaccine design. Here we describe a detailed protocol for an in vitro assay based on the enzyme‐linked immunosorbent assay (ELISA) to assess mucosal antibody response to SARS‐CoV‐2 spike protein in human saliva. © 2024 The Authors. Current Protocols published by Wiley Periodicals LLC.
Basic Protocol: ELISA measurement of mucosal antibodies to SARS‐CoV‐2 spike protein in human saliva - Characterization of antibodies targeting severe fever with thrombocytopenia syndrome virus glycoprotein Gc
Kaori Sano; Miyuki Kimura; Akiko Sataka; Hideki Hasegawa; Hideki Tani; Tadaki Suzuki
Archives of Virology, 2024年03月
研究論文(学術雑誌) - Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire
Masashi Shingai; Sayaka Iida; Naoko Kawai; Mamiko Kawahara; Toshiki Sekiya; Marumi Ohno; Naoki Nomura; Chimuka Handabile; Tomomi Kawakita; Ryosuke Omori; Junya Yamagishi; Kaori Sano; Akira Ainai; Tadaki Suzuki; Kazuo Ohnishi; Kimihito Ito; Hiroshi Kida
Journal of Virology, American Society for Microbiology, 2024年02月07日
研究論文(学術雑誌), As specific interactions between antigens and cell-surface antibodies trigger the proliferation of B-cell clones, the frequency of each antibody sequence in the samples reflects the size of each clonal population. Nevertheless, it is extremely difficult to extract antigen-specific antibody sequences from the comprehensive bulk antibody sequences obtained from blood samples due to repertoire bias influenced by exposure to dietary antigens and other infectious agents. This issue can be addressed by subtracting the background noise from the post-immunization or post-infection repertoire data. In the present study, we propose a method to quantify repertoire data from comprehensive repertoire data. This method allowed subtraction of the background repertoire, resulting in more accurate extraction of expanded antibody repertoires upon influenza virus infection. This accurate extraction of antigen- or infection-specific repertoire information is a useful tool for vaccine evaluation. - Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection.
Disha Bhavsar; Gagandeep Singh; Kaori Sano; Charles Gleason; Komal Srivastava; Juan Manuel Carreno; Viviana Simon; Florian Krammer
mBio, 14, 6, e0228023, 2023年12月19日, [国際誌]
英語, 研究論文(学術雑誌), Antibodies on mucosal surfaces of the upper respiratory tract have been shown to be important for protection from infection with SARS-CoV-2. Here we investigate the induction of serum IgG, saliva IgG, and saliva sIgA after COVID-19 mRNA booster vaccination or breakthrough infections. - Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products.
Kimberley Cousins; Kaori Sano; Brandon Lam; Katharina Röltgen; Disha Bhavsar; Gagandeep Singh; Oliver McRae; Stephanie Jeong; Nouran Aboelregal; Hsi-En Ho; Scott Boyd; Florian Krammer; Charlotte Cunningham-Rundles
The journal of allergy and clinical immunology. In practice, 11, 8, 2534, 2541, 2023年08月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: For patients with primary antibody deficiency, the first line of therapy is replacement with immunoglobulin (Ig) products. Prior to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, Ig products did not contain antibodies with specificity for this virus, and there have been limited data on the antibodies present in the Ig products in current use. OBJECTIVE: To quantitatively examine SARS-CoV-2 antibodies in current Ig products. METHODS: We examined 142 unique lots of 11 different Ig products intended for intravenous and/or subcutaneous delivery for IgG-binding activities against recombinant SARS-CoV-2 receptor binding domain, spike, and nucleocapsid proteins by enzyme-linked immunosorbent assays. In addition, to assess functionality, 48 of these unique lots were assessed for their ability to inhibit the variants SARS-CoV-2 Ancestral, Alpha, Beta, Delta, and Omicron spike binding to angiotensin-converting enzyme 2 (ACE2). RESULTS: Significantly increased antibody values were observed for products manufactured after the year 2020 (expiration dates 2023-2024), as compared with Ig products before 2020 (prepandemic). Sixty percent and 85% of the Ig products with expiration dates of 2023 and 2024 were positive for antibody to SARS-CoV-2 proteins, respectively. The area under the curve values were significantly higher in products with later expiration dates. Later dates of expiration were also strongly correlated with inhibition of ACE2-binding activity; however, a decline in inhibition activity was observed with later variants. CONCLUSIONS: Overall, more recent Ig products (expiration dates 2023-2025) contained significantly higher binding and inhibition activities against SARS-CoV-2 proteins, compared with earlier, or prepandemic products. Normal donor SARS-CoV-2 antibodies are capable of inhibiting ACE2-binding activities and may provide a therapeutic benefit for patients who do not make a robust vaccine response. - Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan
Reiko Shimbashi; Teiichiro Shiino; Akira Ainai; Saya Moriyama; Satoru Arai; Saeko Morino; Sayaka Takanashi; Takeshi Arashiro; Motoi Suzuki; Yukimasa Matsuzawa; Kenichiro Kato; Mitsuru Hasegawa; Rie Koshida; Masami Kitaoka; Takafumi Ueno; Hidefumi Shimizu; Hiroyoshi Yuki; Tomoko Takeda; Fukumi Nakamura-Uchiyama; Kashiya Takasugi; Shun Iida; Tomoe Shimada; Hirofumi Kato; Tsuguto Fujimoto; Naoko Iwata-Yoshikawa; Kaori Sano; Souichi Yamada; Yudai Kuroda; Kazu Okuma; Kiyoko Nojima; Noriyo Nagata; Shuetsu Fukushi; Ken Maeda; Yoshimasa Takahashi; Tadaki Suzuki; Makoto Ohnishi; Keiko Tanaka-Taya
Global Health & Medicine, National Center for Global Health and Medicine (JST), 2023年
研究論文(学術雑誌) - SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano; Disha Bhavsar; Gagandeep Singh; Daniel Floda; Komal Srivastava; Charles Gleason; Angela A. Amoako; Dalles Andre; Katherine F. Beach; Maria C. Bermúdez-González; Gianna Cai; Christian Cognigni; Hisaaki Kawabata; Giulio Kleiner; Neko Lyttle; Wanni Mendez; Lubbertus C. F. Mulder; Annika Oostenink; Ariel Raskin; Aria Rooker; Kayla T. Russo; Ashley Beathrese T. Salimbangon; Miti Saksena; Levy A. Sominsky; Johnstone Tcheou; Ania Wajnberg; Juan Manuel Carreño; Viviana Simon; Florian Krammer
Nature Communications, 2022年09月01日
研究論文(学術雑誌) - Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology
Takuya Hemmi; Akira Ainai; Takao Hashiguchi; Minoru Tobiume; Takayuki Kanno; Naoko Iwata-Yoshikawa; Shun Iida; Yuko Sato; Sho Miyamoto; Akira Ueno; Kaori Sano; Shinji Saito; Nozomi Shiwa-Sudo; Noriyo Nagata; Koji Tamura; Ryosuke Suzuki; Hideki Hasegawa; Tadaki Suzuki
Vaccine, Elsevier BV, 2022年08月
研究論文(学術雑誌) - Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model.
Masayuki Shimojima; Satoko Sugimoto; Kunihiko Umekita; Taishi Onodera; Kaori Sano; Hideki Tani; Yuki Takamatsu; Tomoki Yoshikawa; Takeshi Kurosu; Tadaki Suzuki; Yoshimasa Takahashi; Hideki Ebihara; Masayuki Saijo
Viruses, 14, 8, 2022年07月28日, [国際誌]
英語, 研究論文(学術雑誌), Severe fever with thrombocytopenia syndrome (SFTS) is an infectious disease with a high case fatality rate caused by the SFTS virus, and currently there are no approved specific treatments. Neutralizing monoclonal antibodies (mAbs) against the virus could be a therapeutic agent in SFTS treatment, but their development has not sufficiently been carried out. In the present study, mouse and human mAbs exposed to the viral envelope proteins Gn and Gc (16 clones each) were characterized in vitro and in vivo by using recombinant proteins, cell culture with viruses, and an SFTS animal model with IFNAR-/- mice. Neutralization activities against the recombinant vesicular stomatitis virus bearing SFTS virus Gn/Gc as envelope proteins were observed with three anti-Gn and six anti-Gc mAbs. Therapeutic activities were observed among anti-Gn, but not anti-Gc mAbs with neutralizing activities. These results propose an effective strategy to obtain promising therapeutic mAb candidates for SFTS treatment, and a necessity to reveal precise roles of the SFTS virus Gn/Gc proteins. - Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
Ericka Kirkpatrick Roubidoux; Kaori Sano; Meagan McMahon; Juan Manuel Carreño; Christina Capuano; Kaijun Jiang; Viviana Simon; Harm van Bakel; Patrick Wilson; Florian Krammer
Journal of virology, 96, 9, e0033222, 2022年05月11日, [国際誌]
英語, 研究論文(学術雑誌), Influenza virus neuraminidase (NA)-targeting antibodies are an independent correlate of protection against influenza. Antibodies against the NA act by blocking enzymatic activity, preventing virus release and transmission. As we advance the development of improved influenza virus vaccines that incorporate standard amounts of NA antigen, it is important to identify the antigenic targets of human monoclonal antibodies (mAbs). Here, we describe escape mutants generated by serial passage of A/Netherlands/602/2009 (H1N1)pdm09 in the presence of human anti-N1 mAbs. We observed escape mutations on the head domain of the N1 protein around the enzymatic site (S364N, N369T, and R430Q) and also detected escape mutations located on the sides and bottom of the NA (N88D, N270D, and Q313K/R). This work increases our understanding of how human antibody responses target the N1 protein. IMPORTANCE As improved influenza virus vaccines are being developed, the influenza virus neuraminidase (NA) is becoming an important new target for immune responses. By identifying novel epitopes of anti-NA antibodies, we can improve vaccine design. Additionally, characterizing escape mutations in these epitopes aids in identifying NA antigenic drift in circulating viruses. - Plasma Exchange Did Not Reduce Viral Load in a Recovered Case of Severe Fever with Thrombocytopenia Syndrome.
Rie Utsunomiya Nishimizu; Seiji Shiota; Toshihiro Ishii; Kaori Sano; Tadaki Suzuki; Hideki Hasegawa; Eishi Miyazaki
Internal medicine (Tokyo, Japan), 61, 2, 253, 256, 2022年01月15日, [国内誌]
英語, 研究論文(学術雑誌), Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease caused by the SFTS virus (SFTSV). There is no specific treatment for SFTS, although several reports have indicated that plasma exchange (PE) can be an effective therapy for severe SFTS. However, whether or not PE can reduce the viral load is unclear. We herein report a woman with SFTS who had her SFTSV viral load measured just before and after PE. While the patient recovered, there was no significant difference in the SFTSV viral load after PE. Our results confirmed that PE itself does not reduce the SFTSV viral load. - A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection.
Naoko Iwata-Yoshikawa; Nozomi Shiwa; Tsuyoshi Sekizuka; Kaori Sano; Akira Ainai; Takuya Hemmi; Michiyo Kataoka; Makoto Kuroda; Hideki Hasegawa; Tadaki Suzuki; Noriyo Nagata
Science advances, 8, 1, eabh3827, 2022年01月07日, [国際誌]
英語, 研究論文(学術雑誌), One safety concern during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine development has been the vaccine-associated enhanced disease, which is characterized by eosinophilic immunopathology and T helper cell type 2 (TH2)–biased immune responses with insufficient neutralizing antibodies. In this study, we established a lethal animal model using BALB/c mice and a mouse-passaged isolate (QHmusX) from a European lineage of SARS-CoV-2. The QHmusX strain induced acute respiratory illness, associated with diffuse alveolar damage and pulmonary edema, in TH2-prone adult BALB/c mice, but not in young mice or TH1-prone C57BL/6 mice. We also showed that immunization of adult BALB/c mice with recombinant spike protein without appropriate adjuvant caused eosinophilic immunopathology with TH2-shifted immune response and insufficient neutralizing antibodies after QHmusX infection. This lethal mouse model is useful for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection and may provide new insights into the disease pathogenesis of SARS-CoV-2. - A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.
Weina Sun; Yonghong Liu; Fatima Amanat; Irene González-Domínguez; Stephen McCroskery; Stefan Slamanig; Lynda Coughlan; Victoria Rosado; Nicholas Lemus; Sonia Jangra; Raveen Rathnasinghe; Michael Schotsaert; Jose L Martinez; Kaori Sano; Ignacio Mena; Bruce L Innis; Ponthip Wirachwong; Duong Huu Thai; Ricardo Das Neves Oliveira; Rami Scharf; Richard Hjorth; Rama Raghunandan; Florian Krammer; Adolfo García-Sastre; Peter Palese
Nature communications, 12, 1, 6197, 6197, 2021年10月27日, [国際誌]
英語, 研究論文(学術雑誌), Rapid development of COVID-19 vaccines has helped mitigating SARS-CoV-2 spread, but more equitable allocation of vaccines is necessary to limit the global impact of the COVID-19 pandemic and the emergence of additional variants of concern. We have developed a COVID-19 vaccine candidate based on Newcastle disease virus (NDV) that can be manufactured at high yields in embryonated eggs. Here, we show that the NDV vector expressing an optimized spike antigen (NDV-HXP-S) is a versatile vaccine inducing protective antibody responses. NDV-HXP-S can be administered intramuscularly as inactivated vaccine or intranasally as live vaccine. We show that NDV-HXP-S GMP-produced in Vietnam, Thailand and Brazil is effective in the hamster model. Furthermore, we show that intramuscular vaccination with NDV-HXP-S reduces replication of tested variants of concerns in mice. The immunity conferred by NDV-HXP-S effectively counteracts SARS-CoV-2 infection in mice and hamsters. - Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses
Osamu Kotani; Yasushi Suzuki; Shinji Saito; Akira Ainai; Akira Ueno; Takuya Hemmi; Kaori Sano; Koshiro Tabata; Masaru Yokoyama; Tadaki Suzuki; Hideki Hasegawa; Hironori Sato
Viruses, 13, 9, 1733, 1733, MDPI AG, 2021年08月31日
研究論文(学術雑誌), The stalk domain of influenza virus envelope glycoprotein hemagglutinin (HA) constitutes the axis connecting the head and transmembrane domains, and plays pivotal roles in conformational rearrangements of HA for virus infection. Here we characterized molecular interactions between the anti-HA stalk neutralization antibody F11 and influenza A(H1N1)pdm09 HA to understand the structural basis of the actions and modifications of this antibody. In silico structural analyses using a model of the trimeric HA ectodomain indicated that the F11 Fab fragment has physicochemical properties, allowing it to crosslink two HA monomers by binding to a region near the proteolytic cleavage site of the stalk domain. Interestingly, the F11 binding allosterically caused a marked suppression of the structural dynamics of the HA cleavage loop and flanking regions. Structure-guided mutagenesis of the F11 antibody revealed a critical residue in the F11 light chain for the F11-mediated neutralization. Finally, the mutagenesis led to identification of a unique F11 derivative that can neutralize both F11-sensitive and F11-resistant A(H1N1)pdm09 viruses. These results raise the possibility that F11 sterically and physically disturbs proteolytic cleavage of HA for the ordered conformational rearrangements and suggest that in silico guiding experiments can be useful to create anti-HA stalk antibodies with new phenotypes. - Propagation of activated B cells by in vitro SFTSV infection of human peripheral blood mononuclear cells.
Yuji Wada; Sho Miyamoto; Shun Iida; Kaori Sano; Yuko Sato; Akira Ainai; Kumpei Saito; Harutaka Katano; Hideki Hasegawa; Tadaki Suzuki
The Journal of infectious diseases, 225, 2, 269, 281, 2021年07月05日, [国際誌]
英語, 研究論文(学術雑誌), Severe fever with thrombocytopenia syndrome (SFTS) is an emerging, life-threatening tick-borne viral hemorrhagic fever (VHF) caused by SFTS virus (SFTSV). Transient appearance of plasmablastic lymphocytes in the peripheral blood of SFTS cases has been reported; however, the pathological significance of this transient burst in peripheral blood plasmablastic lymphocytes is unclear. Here, we show that SFTSV infection of human peripheral blood mononuclear cells (PBMCs) in vitro induced propagation of atypical lymphocytes. These atypical lymphocytes were activated B cells, which were induced by secretory factors other than viral particles; these factors were secreted by SFTSV-infected B cells. Activated B cells shared morphological and immunophenotypic characteristics with B cells of plasmablast lineage observed in peripheral blood and autopsy tissues of SFTS cases. This suggests that SFTSV-infected B cells secrete factors that induce B cell differentiation to plasmablasts, which may play an important role in pathogenesis of SFTS through the SFTSV-B cell axis. - Virus-infected peripheral blood plasmablasts in a patient with severe fever with thrombocytopenia syndrome.
Toru Takahashi; Kaori Sano; Tadaki Suzuki; Takuro Matsumura; Kohei Sakai; Takayuki Tominaga; Yuko Sato; Harutaka Katano; Hideki Hasegawa
International journal of hematology, 113, 3, 436, 440, 2021年03月, [査読有り], [筆頭著者], [国内誌]
英語, 研究論文(学術雑誌), Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne viral hemorrhagic disease with a high fatality rate. It is caused by the SFTS virus and is endemic in East Asian countries such as China, South Korea, and Japan. Previous studies have shown that plasmablasts appear transiently in peripheral blood during the acute phase of SFTS, but do not specify the characteristics of these plasmablasts. In this report, we describe the features of peripheral blood plasmablasts in a patient with SFTS. Immunohistochemical and immunofluorescence staining detected a small number of atypical lymphocytes expressing the SFTS virus antigen among peripheral leukocytes in a blood sample. The phenotype of the virus-infected cells was CD27+, CD38+, MUM1+, and CD138+, which is consistent with that of plasmablasts. This novel study demonstrates that plasmablasts in the peripheral blood of patients with SFTS are targets of the SFTS virus. - SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
Seiya Ozono; Yanzhao Zhang; Hirotaka Ode; Kaori Sano; Toong Seng Tan; Kazuo Imai; Kazuyasu Miyoshi; Satoshi Kishigami; Takamasa Ueno; Yasumasa Iwatani; Tadaki Suzuki; Kenzo Tokunaga
Nature communications, 12, 1, 848, 848, 2021年02月08日, [国際誌]
英語, 研究論文(学術雑誌), The causative agent of the COVID-19 pandemic, SARS-CoV-2, is steadily mutating during continuous transmission among humans. Such mutations can occur in the spike (S) protein that binds to the ACE2 receptor and is cleaved by TMPRSS2. However, whether S mutations affect SARS-CoV-2 cell entry remains unknown. Here, we show that naturally occurring S mutations can reduce or enhance cell entry via ACE2 and TMPRSS2. A SARS-CoV-2 S-pseudotyped lentivirus exhibits substantially lower entry than that of SARS-CoV S. Among S variants, the D614G mutant shows the highest cell entry, as supported by structural and binding analyses. Nevertheless, the D614G mutation does not affect neutralization by antisera against prototypic viruses. Taken together, we conclude that the D614G mutation increases cell entry by acquiring higher affinity to ACE2 while maintaining neutralization susceptibility. Based on these findings, further worldwide surveillance is required to understand SARS-CoV-2 transmissibility among humans. - Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Hideki Tani; Miyuki Kimura; Long Tan; Yoshihiro Yoshida; Tatsuhiko Ozawa; Hiroyuki Kishi; Shuetsu Fukushi; Masayuki Saijo; Kaori Sano; Tadaki Suzuki; Hitoshi Kawasuji; Akitoshi Ueno; Yuki Miyajima; Yasutaka Fukui; Ippei Sakamaki; Yoshihiro Yamamoto; Yoshitomo Morinaga
Virology journal, 18, 1, 16, 16, 2021年01月12日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is now classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly pathogenic in humans and is classified as a biosafety level (BSL)-3 pathogen, which makes manipulating it relatively difficult due to its infectious nature. METHODS: To circumvent the need for BSL-3 laboratories, an alternative assay was developed that avoids live virus and instead uses a recombinant VSV expressing luciferase and possesses the full length or truncated spike proteins of SARS-CoV-2. Furthermore, to measure SARS-CoV-2 neutralizing antibodies under BSL2 conditions, a chemiluminescence reduction neutralization test (CRNT) for SARS-CoV-2 was developed. The neutralization values of the serum samples collected from hospitalized patients with COVID-19 or SARS-CoV-2 PCR-negative donors against the pseudotyped virus infection evaluated by the CRNT were compared with antibody titers determined from an enzyme-linked immunosorbent assay (ELISA) or an immunofluorescence assay (IFA). RESULTS: The CRNT, which used whole blood collected from hospitalized patients with COVID-19, was also examined. As a result, the inhibition of pseudotyped virus infection was specifically observed in both serum and whole blood and was also correlated with the results of the IFA. CONCLUSIONS: In conclusion, the CRNT for COVID-19 is a convenient assay system that can be performed in a BSL-2 laboratory with high specificity and sensitivity for evaluating the occurrence of neutralizing antibodies against SARS-CoV-2. - The peripheral T cell population is associated with pneumonia severity in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus 2
Noriyo Nagata; Naoko Iwata-Yoshikawa; Kaori Sano; Akira Ainai; Nozomi Shiwa; Masayuki Shirakura; Noriko Kishida; Tomoko Arita; Yasushi Suzuki; Toshihiko Harada; Yasuhiro Kawai; Yasushi Ami; Shun Iida; Harutaka Katano; Seiichiro Fujisaki; Tsuyoshi Sekizuka; Hiroyuki Shimizu; Tadaki Suzuki; Hideki Hasegawa
2021年01月07日 - Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers.
Tetsuya Suzuki; Kayoko Hayakawa; Akira Ainai; Naoko Iwata-Yoshikawa; Kaori Sano; Noriyo Nagata; Tadaki Suzuki; Yuji Wakimoto; Yutaro Akiyama; Yusuke Miyazato; Keiji Nakamura; Satoshi Ide; Hidetoshi Nomoto; Takato Nakamoto; Masayuki Ota; Yuki Moriyama; Yuko Sugiki; Sho Saito; Shinichiro Morioka; Masahiro Ishikane; Noriko Kinoshita; Satoshi Kutsuna; Norio Ohmagari
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 27, 1, 120, 122, 2021年01月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), INTRODUCTION: Information on the effectiveness of personal protective equipment (PPE) for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among healthcare workers (HCWs), especially among HCWs with frequent contact with patients with SARS-CoV-2, is limited. METHODS: We conducted a prospective cohort study on 49 HCWs who worked in close contact with patients with SARS-CoV-2 infection. HCWs had blood samples taken every 2 weeks to test for SARS-CoV-2 antibodies using two different types of assay. RESULTS: Forty-nine participants (31 nurses, 15 doctors, 3 other workers) were enrolled. In total, 112 blood samples are obtained from participants. The median work days in 2 weeks was 9 (interquartile range (IQR): 5-10) days. In a single work day, 30 of the 49 participants (61.5%) had contact with patients with suspected or conformed SARS-CoV-2 at least 8 times, and approximately 60% of participants had more than 10 min of contact with a single patient. The median self-reported compliance to PPE was 90% (IQR: 80-100%). Seven participants tested positive for SARS-CoV-2 antibody using enzyme-linked immunosorbent assay (ELISA); however, none were seropositive for SARS-CoV-2 neutralizing antibody, so the positive ELISA results were assumed to be false-positive. CONCLUSIONS: The study provides evidence that appropriate PPE is sufficient to prevent infection amongHCWs. It is necessary to establish a system that provides a stable supply of PPE for HCWs to perform their duties. - An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.
Kaori Sano; Shinji Saito; Tadaki Suzuki; Osamu Kotani; Akira Ainai; Elly van Riet; Koshiro Tabata; Kumpei Saito; Yoshimasa Takahashi; Masaru Yokoyama; Hironori Sato; Takahiro Maruno; Kaede Usami; Susumu Uchiyama; Kiyoko Ogawa-Goto; Hideki Hasegawa
PloS one, 16, 1, e0245244, 2021年, [査読有り], [筆頭著者], [国際誌]
英語, 研究論文(学術雑誌), IgA antibodies, which are secreted onto the mucosal surface as secretory IgA antibodies (SIgAs), play an important role in preventing influenza virus infection. A recent study reported that anti-hemagglutinin (HA) head-targeting antibodies increase anti-viral functions such as hemagglutination inhibition (HI) and virus neutralization (NT), in addition to HA binding activity (reactivity) via IgA polymerization. However, the functional properties of anti-viral IgA antibodies with mechanisms of action distinct from those of anti-HA head-targeting antibodies remain elusive. Here, we characterized the functional properties of IgG, monomeric IgA, and polymeric IgA anti-HA stalk-binding clones F11 and FI6, and B12 (a low affinity anti-HA stalk clone), as well as Fab-deficient (ΔFab) IgA antibodies. We found that IgA polymerization impacts the functional properties of anti-HA stalk antibodies. Unlike anti-HA head antibodies, the anti-viral functions of anti-HA stalk antibodies were not simply enhanced by IgA polymerization. The data suggest that two modes of binding (Fab paratope-mediated binding to the HA stalk, and IgA Fc glycan-mediated binding to the HA receptor binding site (RBS)) occur during interaction between anti-stalk HA IgA antibodies and HA. In situations where Fab paratope-mediated binding to the HA stalk exceeded IgA Fc glycan-mediated binding to HA RBS, IgA polymerization increased anti-viral functions. By contrast, when IgA Fc glycan-mediated binding to the HA RBS was dominant, anti-viral activity will fall upon IgA polymerization. In summary, the results suggest that coordination between these two independent binding modules determines whether IgA polymerization has a negative or positive effect on the anti-viral functions of anti-HA stalk IgA antibodies. - Characterization of pseudotyped vesicular stomatitis virus bearing the heartland virus envelope glycoprotein.
Miyuki Kimura; Kazutaka Egawa; Tatsuhiko Ozawa; Hiroyuki Kishi; Masayuki Shimojima; Satoshi Taniguchi; Shuetsu Fukushi; Hikaru Fujii; Hiroshi Yamada; Long Tan; Kaori Sano; Harutaka Katano; Tadaki Suzuki; Shigeru Morikawa; Masayuki Saijo; Hideki Tani
Virology, 556, 124, 132, 2020年10月25日, [国際誌]
英語, 研究論文(学術雑誌), The heartland virus (HRTV) is a novel phlebovirus that causes severe infections in the USA and closely related to the severe fever thrombocytopenia syndrome virus (SFTSV), a causative agent for SFTS in Asia. The entry mechanisms of HRTV remain unclear. Here, we developed the pseudotyped vesicular stomatitis virus bearing the HRTV glycoprotein (GP) (HRTVpv), and the antigenicity and the entry mechanisms of HRTV were analyzed. HRTVpv was neutralized by anti-SFTSV Gc antibody, but not the anti-SFTSV Gn antibodies. Entry of HRTVpv to cells was inhibited by bafilomycin A1 and dynasore, and but it was enhanced in cells overexpressed with C-type lectins. Production of infectious HRTVpv and SFTSVpv was reduced by Nn-DNJ, α-glucosidase inhibitor. The entry of HRTV occurs via pH- and dynamin-dependent endocytosis. Furthermore, Nn-DNJ may be a possible therapeutic agent against HRTV and SFTSV. - Stereotyped B-cell response that counteracts antigenic variation of influenza viruses.
Keisuke Tonouchi; Yu Adachi; Saya Moriyama; Kaori Sano; Koshiro Tabata; Keigo Ide; Haruko Takeyama; Tadaki Suzuki; Yoshimasa Takahashi
International immunology, 32, 9, 613, 621, 2020年09月08日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Influenza A subtypes are categorized into group 1 and group 2 based on the hemagglutinin (HA) sequence. Owing to the phylogenetic distance of HAs in different groups, antibodies that bind multiple HA subtypes across different groups are extremely rare. In this study, we demonstrated that an immunization with acid-treated HA antigen elicits germinal center (GC) B cells that bind multiple HA subtypes in both group 1 and group 2. The cross-group GC B cells utilized mostly one VH gene (1S56) and exhibited a sign of clonal evolution within GCs. The 1S56-lineage IgGs derived from GC B cells were able to bind to HA protein on the infected cell surface but not to the native form of HA protein, suggesting the cryptic nature of the 1S56 epitope and its exposure in infected cells. Finally, the 1S56-lineage IgGs provided protection against lethal infection in an Fc-dependent manner, independent of the virus-neutralizing activity. Thus, we identified 1S56-lineage antibodies as a unique stereotype for achieving cross-group influenza specificity. The antigens exposing the 1S56 epitope may be good candidates for broadly protective immunogens. - Genetic diversity of enterovirus G detected in faecal samples of wild boars in Japan: identification of novel genotypes carrying a papain-like cysteine protease sequence.
Ayaka Nagata; Yuya Sekiguchi; Toru Oi; Fujiko Sunaga; Hiroo Madarame; Ryo Imai; Kaori Sano; Yukie Katayama; Tsutomu Omatsu; Mami Oba; Tetsuya Furuya; Junsuke Shirai; Tamaki Okabayashi; Naoaki Misawa; Tomoichiro Oka; Tetsuya Mizutani; Makoto Nagai
The Journal of general virology, 101, 8, 840, 852, 2020年08月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The genetic diversity of enterovirus G (EV-G) was investigated in the wild-boar population in Japan. EV-G-specific reverse transcription PCR demonstrated 30 (37.5 %) positives out of 80 faecal samples. Of these, viral protein 1 (VP1) fragments of 20 samples were classified into G1 (3 samples), G4 (1 sample), G6 (2 samples), G8 (4 samples), G11 (1 sample), G12 (7 samples), G14 (1 sample) and G17 (1 sample), among which 11 samples had a papain-like cysteine protease (PL-CP) sequence, believed to be the first discoveries in G1 (2 samples) or G17 (1 sample) wild-boar EV-Gs, and in G8 (2 samples) or G12 (6 samples) EV-Gs from any animals. Sequences of the non-structural protein regions were similar among EV-Gs possessing the PL-CP sequence (PL-CP EV-Gs) regardless of genotype or origin, suggesting the existence of a common ancestor for these strains. Interestingly, for the two G8 and two G12 samples, the genome sequences contained two versions, with or without the PL-CP sequence, together with the homologous 2C/PL-CP and PL-CP/3A junction sequences, which may explain how the recombination and deletion of the PL-CP sequences occured in the PL-CP EV-G genomes. These findings shed light on the genetic plasticity and evolution of EV-G. - Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections.
Tadaki Suzuki; Yuko Sato; Kaori Sano; Takeshi Arashiro; Harutaka Katano; Noriko Nakajima; Masayuki Shimojima; Michiyo Kataoka; Kenta Takahashi; Yuji Wada; Shigeru Morikawa; Shuetsu Fukushi; Tomoki Yoshikawa; Masayuki Saijo; Hideki Hasegawa
The Journal of clinical investigation, 130, 2, 799, 812, 2020年02月03日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Severe fever with thrombocytopenia syndrome (SFTS) is an emerging hemorrhagic fever caused by a tick-borne banyangvirus and is associated with high fatality. Despite increasing incidence of SFTS and serious public health concerns in East Asia, the pathogenesis of lethal SFTS virus (SFTSV) infection in humans is not fully understood. Numbers of postmortem examinations to determine target cells of the viral infection have so far been limited. Here we showed that B cells differentiating into plasmablasts and macrophages in secondary lymphoid organs were targets for SFTSV at the end stage of lethal infection, and the majority of SFTSV-infected cells were B cell-lineage lymphocytes. In affected individuals, B cell-lineage lymphocytes with SFTSV infection were widely distributed in both lymphoid and nonlymphoid organs, and infiltration of these cells into the capillaries of the organs could be observed occasionally. Moreover, a human plasmablastic lymphoma cell line, PBL-1, was susceptible to SFTSV propagation and had a similar immunophenotype to that of target cells of SFTSV in fatal SFTS. PBL-1 can therefore provide a potential in vitro model for human SFTSV infection. These results extend our understanding of the pathogenesis of human lethal SFTSV infection and can facilitate the development of SFTSV countermeasures. - Complete genome sequencing and genetic analysis of a Japanese porcine torovirus strain detected in swine feces.
Yuki Fujii; Yuki Kashima; Fujiko Sunaga; Hiroshi Aoki; Ryo Imai; Kaori Sano; Yukie Katayama; Tsutomu Omatsu; Mami Oba; Tetsuya Furuya; Satoko Tsuzuku; Yoshinao Ouchi; Junsuke Shirai; Tetsuya Mizutani; Tomoichiro Oka; Makoto Nagai
Archives of virology, 165, 2, 471, 477, 2020年02月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Complete genome sequencing and genetic characterization of porcine sapovirus genogroup (G) X and GXI: GVI, GVII, GX, and GXI sapoviruses share common genomic features and form a unique porcine SaV clade.
Fujiko Sunaga; Tsuneyuki Masuda; Hiroshi Aoki; Mika Ito; Kaori Sano; Yuki Naoi; Yukie Katayama; Tsutomu Omatsu; Mami Oba; Tetsuya Furuya; Junsuke Shirai; Tetsuya Mizutani; Tomoichiro Oka; Makoto Nagai
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 75, 103959, 103959, 2019年11月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Sapoviruses (SaVs) are enteric viruses belonging to the family Caliciviridae that infect humans and animals, including pigs. To date, SaVs have been classified into 19 genogroups (G) based on complete VP1 sequences; however, complete genome sequences of some SaV Gs are not yet available. In this study, we determined the full genome sequences of four SaVs (two GX and two GXI SaVs) and analyzed them together with those of other SaVs. The complete genome sequences of GX and GXI SaVs, excluding the poly(A) tails, were 7124, 7142, 7170, and 7179 nucleotides, which were shorter than those of other SaVs, except for porcine GVI and GVII viruses. Genetic characterization revealed that GX SaVs and GXI SaVs shared common features with GVI and GVII viruses, such as the first 10 amino acid residues in the ORF1 coding region, a shorter ORF1 than that of the other genogroups, and the predicted secondary structure of the 5' end of the genome and the starting region of non-structural protein/structural protein junction. Phylogenetic analyses showed that GX and GXI SaVs branched with porcine GVI, GVII, and GIX SaVs and formed a clade consisting of only porcine SaVs. These findings suggest that porcine GX and GXI SaVs together with porcine GVI, GVII, and possibly GIX SaVs, evolved from a common ancestor in the porcine population. - First identification of Sapoviruses in wild boar.
Risako Katsuta; Fujiko Sunaga; Toru Oi; Yen Hai Doan; Satoko Tsuzuku; Yoshihisa Suzuki; Kaori Sano; Yukie Katayama; Tsutomu Omatsu; Mami Oba; Tetsuya Furuya; Yoshinao Ouchi; Junsuke Shirai; Tetsuya Mizutani; Tomoichiro Oka; Makoto Nagai
Virus research, 271, 197680, 197680, 2019年10月02日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Sapoviruses (SaVs) are enteric viruses that have been detected in human and animals previously; however, SaVs have not been identified in wild boar yet. Using a metagenomics approach, we identified SaVs in fecal samples of free-living wild boars in Japan for the first time. Six of the 48 specimens identified belonged to one genogroup (G)III, one GV and four GVI SaV sequence reads. We successfully determined complete genome of GV and GVI SaV strains using the long reverse transcription PCR strategy and the 5' rapid amplification of cDNA end method. Phylogenetic tree analysis and pairwise distance calculation revealed that GV SaV detected from wild boar was related to recently assigned GV.5 strains from pig, while GVI SaV was assigned to a new genotype within GVI. Moreover, wild boar may act as a reservoir for transmission of SaVs to the pig population (and vice versa) because GIII, GV, and GVI SaVs were all detected in pigs previously. - Phylogenetic analysis of novel posaviruses detected in feces of Japanese pigs with posaviruses and posa-like viruses of vertebrates and invertebrates.
Hiroshi Aoki; Fujiko Sunaga; Hideharu Ochiai; Tsuneyuki Masuda; Mika Ito; Masataka Akagami; Yuki Naoi; Kaori Sano; Yukie Katayama; Tsutomu Omatsu; Mami Oba; Shoichi Sakaguchi; Tetsuya Furuya; Yoshinao Ouchi; Junsuke Shirai; Tetsuya Mizutani; Tomoichiro Oka; Makoto Nagai
Archives of virology, 164, 8, 2147, 2151, 2019年08月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Posaviruses and posa-like viruses are unclassified viruses with sequence similarity to viruses of the order Picornavirales. They have been reported in various vertebrates and invertebrates. We identified 11 posavirus-like sequences in porcine feces and performed phylogenic analysis. Previously reported Japanese posaviruses and those identified in this study clustered with posavirus 1, 4, and 7 and husavirus 1, while five viruses branched into three independent lineages, tentatively named posavirus 10, 11, and 12. Interestingly, posaviruses, except for posavirus 8 and 9, husaviruses, and rasaviruses, formed a cluster consisting of viruses only from pigs, humans, and rats, while posavirus 8 and 9, fisavirus, and basaviruses clustered with posa-like viruses from invertebrates. - Complete genomic analysis and molecular characterization of Japanese porcine sapeloviruses.
Fujiko Sunaga; Tsuneyuki Masuda; Mika Ito; Masataka Akagami; Yuki Naoi; Kaori Sano; Yukie Katayama; Tsutomu Omatsu; Mami Oba; Shoichi Sakaguchi; Tetsuya Furuya; Hiroshi Yamasato; Yoshinao Ouchi; Junsuke Shirai; Tetsuya Mizutani; Makoto Nagai
Virus genes, 55, 2, 198, 208, 2019年04月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The Porcine Sapelovirus (PSV) is an enteric virus of pigs that can cause various disorders. However, there are few reports that describe the molecular characteristics of the PSV genome. In this study, almost the entire genomes of 23 PSVs detected in Japanese pigs were analyzed using bioinformatics. Analysis of the cis-active RNA elements showed that the predicted secondary structures of the internal ribosome entry site in the 5' untranslated region (UTR) and a cis-replication element in the 2C coding region were conserved among PSVs. In contrast, those at the 3' UTR were different for different PSVs; however, tertiary structures between domains were conserved across all PSVs. Phylogenetic analysis of nucleotide sequences of the complete VP1 region showed that PSVs exhibited sequence diversity; however, they could not be grouped into genotypes due to the low bootstrap support of clusters. The insertion and/or deletion patterns in the C-terminal VP1 region were not related to the topology of the VP1 tree. The 3CD phylogenetic tree was topologically different from the VP1 tree, and PSVs from the same country were clustered independently. Recombination analysis revealed that recombination events were found upstream of the P2 region and some recombination breakpoints involved insertions and/or deletions in the C-terminal VP1 region. These findings demonstrate that PSVs show genetic diversity and frequent recombination events, particularly in the region upstream of the P2 region; however, PSVs could currently not be classified into genotypes and conserved genetic structural features of the cis-active RNA elements are observed across all PSVs. - Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing.
Lin Sun; Naoko Kono; Hiroyuki Toh; Hanbing Xue; Kaori Sano; Tadaki Suzuki; Akira Ainai; Yasuko Orba; Junya Yamagishi; Hideki Hasegawa; Yoshimasa Takahashi; Shigeyuki Itamura; Kazuo Ohnishi
Journal of visualized experiments : JoVE, 145, 2019年03月15日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), The immense adaptability of antigen recognition by antibodies is the basis of the acquired immune system. Despite our understanding of the molecular mechanisms underlying the production of the vast repertoire of antibodies by the acquired immune systems, it has not yet been possible to arrive at a global view of a complete antibody repertoire. In particular, B cell repertoires have been regarded as a black box because of their astronomical number of antibody clones. However, next-generation sequencing technologies are enabling breakthroughs to increase our understanding of the B cell repertoire. In this report, we describe a simple and efficient method to visualize and analyze whole individual mouse and human antibody repertoires. From the immune organs, representatively from spleen in mice and peripheral blood mononuclear cells in humans, total RNA was prepared, reverse transcribed, and amplified using the 5'-RACE method. Using a universal forward primer and antisense primers for the antibody class-specific constant domains, antibody mRNAs were uniformly amplified in proportions reflecting their frequencies in the antibody populations. The amplicons were sequenced by next-generation sequencing (NGS), yielding more than 105 antibody sequences per immunological sample. We describe the protocols for antibody sequence analyses including V(D)J-gene-segment annotation, a bird's-eye view of the antibody repertoire, and our computational methods. - IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody.
Shinji Saito; Kaori Sano; Tadaki Suzuki; Akira Ainai; Yuki Taga; Tomonori Ueno; Koshiro Tabata; Kumpei Saito; Yuji Wada; Yuki Ohara; Haruko Takeyama; Takato Odagiri; Tsutomu Kageyama; Kiyoko Ogawa-Goto; Pretty Multihartina; Vivi Setiawaty; Krisna Nur Andriana Pangesti; Hideki Hasegawa
PLoS pathogens, 15, 1, e1007427, 2019年01月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Mucosal immunoglobulins comprise mainly secretory IgA antibodies (SIgAs), which are the major contributor to pathogen-specific immune responses in mucosal tissues. These SIgAs are highly heterogeneous in terms of their quaternary structure. A recent report shows that the polymerization status of SIgA defines their functionality in the human upper respiratory mucosa. Higher order polymerization of SIgA (i.e., tetramers) leads to a marked increase in neutralizing activity against influenza viruses. However, the precise molecular mechanisms underlying the effects of SIgA polymerization remain elusive. Here, we developed a method for generating recombinant tetrameric monoclonal SIgAs. We then compared the anti-viral activities of these tetrameric SIgAs, which possessed variable regions identical to that of a broadly neutralizing anti-influenza antibody F045-092 against influenza A viruses, with that of monomeric IgG or IgA. The tetrameric SIgA showed anti-viral inhibitory activity superior to that of other forms only when the antibody exhibits low-affinity binding to the target. By contrast, SIgA tetramerization did not substantially modify anti-viral activity against targets with high-affinity binding. Taken together, the data suggest that tetramerization of SIgA improved target breadth, but not peak potency of antiviral functions of the broadly neutralizing anti-influenza antibody. This phenomenon presumably represents one of the mechanisms by which SIgAs present in human respiratory mucosa prevent infection by antigen-drifted influenza viruses. Understanding the mechanisms involved in cross neutralization of viruses by SIgAs might facilitate the development of vaccine strategies against viral infection of mucosal tissues. - Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics.
Kaori Sano; Akira Ainai; Tadaki Suzuki; Hideki Hasegawa
Expert review of vaccines, 17, 8, 687, 696, 2018年08月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), INTRODUCTION: Intranasal influenza vaccines are expected to confer protection among vaccine recipients by successful induction of mucosal immune response in the upper respiratory tract. Though only live attenuated influenza virus vaccines (LAIVs) are licensed and available for intranasal use in humans today, intranasal inactivated influenza vaccines (IIVs) are currently under reconsideration as a promising intranasal influenza vaccine. AREAS COVERED: This review addresses the history of intranasal IIV research and development, along with a summary of the studies done so far to address the mechanism of action of intranasal IIVs. EXPERT COMMENTARY: From numerous in vitro and in vivo studies, it has been shown that intranasal IIVs can protect hosts from a broad spectrum of influenza virus strains. In-depth studies of the mucosal antibody response following intranasal IIV administration have also elucidated the detailed functions of secretory IgA (immunoglobulin A) antibodies which are responsible for the mechanism of action of intranasal vaccines. Safe and effective intranasal IIVs are expected to be an important tool to combat seasonal influenza. - IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
Yoshihiko Terauchi; Kaori Sano; Akira Ainai; Shinji Saito; Yuki Taga; Kiyoko Ogawa-Goto; Shin-Ichi Tamura; Takato Odagiri; Masato Tashiro; Mikiya Fujieda; Tadaki Suzuki; Hideki Hasegawa
Human vaccines & immunotherapeutics, 14, 6, 1351, 1361, 2018年06月03日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Unlike the current injectable influenza vaccines, intranasally administered influenza vaccines induce influenza virus-specific IgA antibodies in the local respiratory mucosa as well as IgG antibodies in the systemic circulation. Our previous study showed that after five volunteers underwent intranasal administration with inactivated H3N2 or H5N1 vaccines, their IgA antibodies on the upper respiratory tract were present as monomers, dimers, and multimers (trimers and tetramers). Moreover, the multimers associated with the highest virus neutralizing activity. However, it has remained elusive whether a more practical intranasal vaccination strategy could induce the high-performance IgA multimers in the nasal mucosa. In the present study, volunteers were administered with two doses of the intranasal trivalent whole-virus inactivated influenza vaccine and showed that in nasal wash samples the amount of multimeric IgA correlated positively with virus neutralizing titers, indicating that the multimeric IgA antibodies play an important role in the antiviral activity at the nasal mucosa. Surface plasmon resonance analysis of the binding dynamics of nasal wash derived IgA monomers, dimers, and multimers against recombinant trimeric influenza virus HA showed that sample fractions containing IgA multimers dissociated from HA less well than sample fractions without IgA multimers. Thus, IgA multimers may "stick" to the antigen more tightly than the other structures. In summary, intranasal administration of two doses of multivalent inactivated influenza vaccines induced multimeric IgA. Multimerization of mucosal IgA antibodies conferred higher neutralizing activity against viruses in the nasal mucosa, possibly by increasing their cohesion to virus antigens. - Application of HTLV-1 tax transgenic mice for therapeutic intervention.
Hideki Hasegawa; Kaori Sano; Akira Ainai; Tadaki Suzuki
Advances in biological regulation, 68, 10, 12, 2018年05月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Adult T-cell leukemia-lymphoma (ATL) is a refractory T-cell malignancy caused by infection of human T-cell leukemia virus type I (HTLV-I). Although the pathogenesis of ATL remains unclear, HTLV-1 oncoprotein Tax plays an important role in pathogenesis (Matsuoka, 2003; Jeang et al., 2004). Chemotherapy resistance of ATL leads the poor prognosis of this disease. In order to understand the pathogenesis and establish an animal model useful for therapy attempts, we have generated HTLV-1 Tax transgenic mice using the Lck proximal promoter to restrict the Tax expression in T-cells. The HTLV-1 Tax transgenic mice developed diffuse large-cell lymphomas and leukemia with the similar features of a clinical, pathological and immunological characteristic of acute ATL. The fulminant disease also developed rapidly in SCID mice after engraftment of mouse ATL cells derived from the transgenic mice. In this review, we introduce the therapeutic attempts using this animal model and discuss the possible signaling pathway for a therapeutic target. - Genetic diversity and intergenogroup recombination events of sapoviruses detected from feces of pigs in Japan.
Moegi Kuroda; Tsuneyuki Masuda; Mika Ito; Yuki Naoi; Yen Hai Doan; Kei Haga; Shinobu Tsuchiaka; Mai Kishimoto; Kaori Sano; Tsutomu Omatsu; Yukie Katayama; Mami Oba; Hiroshi Aoki; Toru Ichimaru; Fujiko Sunaga; Itsuro Mukono; Hiroshi Yamasato; Junsuke Shirai; Kazuhiko Katayama; Tetsuya Mizutani; Tomoichiro Oka; Makoto Nagai
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 55, 209, 217, 2017年11月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - The road to a more effective influenza vaccine: Up to date studies and future prospects.
Kaori Sano; Akira Ainai; Tadaki Suzuki; Hideki Hasegawa
Vaccine, 35, 40, 5388, 5395, 2017年09月25日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌) - Complete genome analysis of porcine kobuviruses from the feces of pigs in Japan
Masataka Akagami; Mika Ito; Kazutaka Niira; Moegi Kuroda; Tsuneyuki Masuda; Kei Haga; Shinobu Tsuchiaka; Yuki Naoi; Mai Kishimoto; Kaori Sano; Tsutomu Omatsu; Hiroshi Aoki; Yukie Katayama; Mami Oba; Tomoichiro Oka; Toru Ichimaru; Hiroshi Yamasato; Yoshinao Ouchi; Junsuke Shirai; Kazuhiko Katayama; Tetsuya Mizutani; Makoto Nagai
VIRUS GENES, 53, 4, 593, 602, 2017年08月, [査読有り]
英語, 研究論文(学術雑誌) - Whole genome analysis of porcine astroviruses detected in Japanese pigs reveals genetic diversity and possible intra-genotypic recombination
Mika Ito; Moegi Kuroda; Tsuneyuki Masuda; Masataka Akagami; Kei Haga; Shinobu Tsuchiaka; Mai Kishimoto; Yuki Naoi; Kaori Sano; Tsutomu Omatsu; Yukie Katayama; Mami Oba; Hiroshi Aoki; Toru Ichimaru; Itsuro Mukono; Yoshinao Ouchi; Hiroshi Yamasato; Junsuke Shirai; Kazuhiko Katayama; Tetsuya Mizutani; Makoto Nagai
INFECTION GENETICS AND EVOLUTION, 50, 38, 48, 2017年06月, [査読有り]
英語, 研究論文(学術雑誌) - Diversity in VP3, NSP3, and NSP4 of rotavirus B detected from Japanese cattle.
Michiko Hayashi-Miyamoto; Toshiaki Murakami; Fujiko Minami-Fukuda; Shinobu Tsuchiaka; Mai Kishimoto; Kaori Sano; Yuki Naoi; Keigo Asano; Toru Ichimaru; Kei Haga; Tsutomu Omatsu; Yukie Katayama; Mami Oba; Hiroshi Aoki; Junsuke Shirai; Motohiko Ishida; Kazuhiko Katayama; Tetsuya Mizutani; Makoto Nagai
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 49, 97, 103, 2017年04月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Bovine rotavirus B (RVB) is an etiological agent of diarrhea mostly in adult cattle. Currently, a few sequences of viral protein (VP)1, 2, 4, 6, and 7 and nonstructural protein (NSP)1, 2, and 5 of bovine RVB are available in the DDBJ/EMBL/GenBank databases, and none have been reported for VP3, NSP3, and NSP4. In order to fill this gap in the genetic characterization of bovine RVB strains, we used a metagenomics approach and sequenced and analyzed the complete coding sequences (CDS) of VP3, NSP3, and NSP4 genes, as well as the partial or complete CDS of other genes of RVBs detected from Japanese cattle. VP3, NSP3, and NSP4 of bovine RVBs shared low nucleotide sequence identities (63.3-64.9% for VP3, 65.9-68.2% for NSP3, and 52.6-56.2% for NSP4) with those of murine, human, and porcine RVBs, suggesting that bovine RVBs belong to a novel genotype. Furthermore, significantly low amino acid sequence identities were observed for NSP4 (36.1-39.3%) between bovine RVBs and the RVBs of other species. In contrast, hydrophobic plot analysis of NSP4 revealed profiles similar to those of RVBs of other species and rotavirus A (RVA) strains. Phylogenetic analyses of all gene segments revealed that bovine RVB strains formed a cluster that branched distantly from other RVBs. These results suggest that bovine RVBs have evolved independently from other RVBs but in a similar manner to other rotaviruses. These findings provide insights into the evolution and diversity of RVB strains. - Development of a one-run real-time PCR detection system for pathogens associated with bovine respiratory disease complex
Mai Kishimoto; Shinobu Tsuchiaka; Sayed Samim Rahpaya; Ayako Hasebe; Keiko Otsu; Satoshi Sugimura; Suguru Kobayashi; Natsumi Komatsu; Makoto Nagai; Tsutomu Omatsu; Yuki Naoi; Kaori Sano; Sachiko Okazaki-Terashima; Mami Oba; Yukie Katayama; Reiichiro Sato; Tetsuo Asai; Tetsuya Mizutani
JOURNAL OF VETERINARY MEDICAL SCIENCE, 79, 3, 517, 523, 2017年03月, [査読有り]
英語, 研究論文(学術雑誌) - Identification of a novel bovine enterovirus possessing highly divergent amino acid sequences in capsid protein
Shinobu Tsuchiaka; Sayed Samim Rahpaya; Konosuke Otomaru; Hiroshi Aoki; Mai Kishimoto; Yuki Naoi; Tsutomu Omatsu; Kaori Sano; Sachiko Okazaki-Terashima; Yukie Katayama; Mami Oba; Makoto Nagai; Tetsuya Mizutani
BMC MICROBIOLOGY, 17, 1, 18, 2017年01月, [査読有り]
英語, 研究論文(学術雑誌) - Identification of further diversity among posaviruses.
Kaori Sano; Yuki Naoi; Mai Kishimoto; Tsuneyuki Masuda; Hitomi Tanabe; Mika Ito; Kazutaka Niira; Kei Haga; Keigo Asano; Shinobu Tsuchiaka; Tsutomu Omatsu; Tetsuya Furuya; Yukie Katayama; Mami Oba; Yoshinao Ouchi; Hiroshi Yamasato; Motohiko Ishida; Junsuke Shirai; Kazuhiko Katayama; Tetsuya Mizutani; Makoto Nagai
Archives of virology, 161, 12, 3541, 3548, 2016年12月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Recently, there have been reports of new members of posavirus-like viruses in the order Picornavirales. In this study, using a metagenomics approach, 11 posavirus-like sequences (>7,000 nucleotides) were detected in 155 porcine fecal samples. Phylogenetic analysis revealed that the newly identified virus sequences, together with other posavirus-like viruses, form distinct clusters within the order Picornavirales, composed of eight genogroups and unassigned sequences based on amino acid sequences of the helicase and RNA-dependent RNA polymerase regions, with <40 % and <50 % sequence identity, respectively. We propose further classifications of highly diverse posavirus populations based on newly identified sequences from Japanese pig feces. - Whole genome sequences of Japanese porcine species C rotaviruses reveal a high diversity of genotypes of individual genes and will contribute to a comprehensive, generally accepted classification system
Kazutaka Niira; Mika Ito; Tsuneyuki Masuda; Toshiya Saitou; Tadatsugu Abe; Satoshi Komoto; Mitsuo Sato; Hiroshi Yamasato; Mai Kishimoto; Yuki Naoi; Kaori Sano; Shinobu Tuchiaka; Takashi Okada; Tsutomu Omatsu; Tetsuya Furuya; Hiroshi Aoki; Yukie Katayama; Mami Oba; Junsuke Shirai; Koki Taniguchi; Tetsuya Mizutani; Makoto Nagai
INFECTION GENETICS AND EVOLUTION, 44, 106, 113, 2016年10月, [査読有り]
英語, 研究論文(学術雑誌) - Detection of Japanese Eel Endothelial Cells-infecting Virus (JEECV) in Mature Japanese Eel Anguilla japonica Caught from Their Spawning Area
Sachiko Okazaki-Terashima; Hiroaki Kurogi; Seinen Chow'; Toshihiro Yamamoto; Noriaki Matsuya; Shigeho Ijiri; Noritaka Mochioka; Shinobu Tsuchiakat; Yuki Naoi; Kaori Sano; Tsutomu Omatsu; Shin-ichi Ono; Hiroshi Kuwada; Tetsuya Mizutani
FISH PATHOLOGY, 51, 2, 64, 66, 2016年06月, [査読有り]
英語, 研究論文(学術雑誌) - Characterization and phylogenetic analysis of a novel picornavirus from swine feces in Japan
Yuki Naoi; Mai Kishimoto; Tsuneyuki Masuda; Mika Ito; Shinobu Tsuchiaka; Kaori Sano; Hiroshi Yamasato; Tsutomu Omatsu; Hiroshi Aoki; Tetsuya Furuya; Yukie Katayama; Mami Oba; Takashi Okada; Junsuke Shirai; Tetsuya Mizutani; Makoto Nagai
ARCHIVES OF VIROLOGY, 161, 6, 1685, 1690, 2016年06月, [査読有り]
英語, 研究論文(学術雑誌) - Detection and molecular characterization of Cryptosporidium and Eimeria species in Philippine bats
Fumi Murakoshi; Frances C. Recuenco; Tsutomu Omatsu; Kaori Sano; Satoshi Taniguchi; Joseph S. Masangkay; Philip Alviola; Eduardo Eres; Edison Cosico; James Alvarez; Yumi Une; Shigeru Kyuwa; Yuki Sugiura; Kentaro Kato
PARASITOLOGY RESEARCH, 115, 5, 1863, 1869, 2016年05月, [査読有り]
英語, 研究論文(学術雑誌) - Detection of novel kobu-like viruses in Japanese black cattle in Japan
Konosuke Otomaru; Yuki Naoi; Kei Haga; Tsutomu Omatsu; Takehiko Uto; Motoya Koizumi; Tsuneyuki Masuda; Hiroshi Yamasato; Hikaru Takai; Hiroshi Aoki; Shinobu Tsuchiaka; Kaori Sano; Sachiko Okazaki; Yukie Katayama; Mami Oba; Tetsuya Furuya; Junsuke Shirai; Kazuhiko Katayama; Tetsuya Mizutani; Makoto Nagai
JOURNAL OF VETERINARY MEDICAL SCIENCE, 78, 2, 321, 324, 2016年02月, [査読有り]
英語, 研究論文(学術雑誌) - Identification and complete genome analysis of a novel bovine picornavirus in Japan
Makoto Nagai; Tsutomu Omatsu; Hiroshi Aoki; Yoshihiro Kaku; Graham J. Belsham; Kei Haga; Yuki Naoi; Kaori Sano; Moeko Umetsu; Mai Shiokawa; Shinobu Tsuchiaka; Tetsuya Furuya; Sachiko Okazaki; Yukie Katayama; Mami Oba; Junsuke Shirai; Kazuhiko Katayama; Tetsuya Mizutani
VIRUS RESEARCH, 210, 205, 212, 2015年12月, [査読有り]
英語, 研究論文(学術雑誌) - Full genome analysis of bovine astrovirus from fecal samples of cattle in Japan: identification of possible interspecies transmission of bovine astrovirus
Makoto Nagai; Tsutomu Omatsu; Hiroshi Aoki; Konosuke Otomaru; Takehiko Uto; Motoya Koizumi; Fujiko Minami-Fukuda; Hikaru Takai; Toshiaki Murakami; Tsuneyuki Masuda; Hiroshi Yamasato; Mai Shiokawa; Shinobu Tsuchiaka; Yuki Naoi; Kaori Sano; Sachiko Okazaki; Yukie Katayama; Mami Oba; Tetsuya Furuya; Junsuke Shirai; Tetsuya Mizutani
ARCHIVES OF VIROLOGY, 160, 10, 2491, 2501, 2015年10月, [査読有り]
英語, 研究論文(学術雑誌) - Detection of a novel herpesvirus from bats in the Philippines
Kaori Sano; Sachiko Okazaki; Satoshi Taniguchi; Joseph S. Masangkay; Roberto Puentespina; Eduardo Eres; Edison Cosico; Nina Quibod; Taisuke Kondo; Hiroshi Shimoda; Yuuki Hatta; Shumpei Mitomo; Mami Oba; Yukie Katayama; Yukiko Sassa; Tetsuya Furuya; Makoto Nagai; Yumi Une; Ken Maeda; Shigeru Kyuwa; Yasuhiro Yoshikawa; Hiroomi Akashi; Tsutomu Omatsu; Tetsuya Mizutani
VIRUS GENES, 51, 1, 136, 139, 2015年08月, [査読有り]
英語, 研究論文(学術雑誌)
- 国家備蓄ワクチン(A/Astrakhan/3212/2020,IDCDC-RG71A)のフェレットを用いた有効性評価
浅沼秀樹; 鈴木康司; 有田知子; 佐々木永太; 白倉雅之; 岸田典子; 佐野芳; 永田典代; 岩田奈織子; 坂井祐介; 志和希; 鈴木忠樹; 乾秀昭; 田辺哲朗; 長谷川秀樹, 日本ワクチン学会学術集会プログラム・抄録集, 29th, 2025年 - 日本人医療従事者におけるOmicron XBB.1.5ワクチン接種後の免疫応答の解析
佐野 芳; 加藤 英明; 長谷川 秀樹; 宮川 敬, 臨床とウイルス, 52, 3, 172, 172, 2024年10月
日本臨床ウイルス学会, 日本語 - IgA四量体化は抗インフルエンザ広域中和抗体の交叉反応性を増強する
齊藤慎二; 佐野芳; 相内章; 田畑耕史郎; 澤洋文; 鈴木忠樹; 長谷川秀樹, 日本生体防御学会学術総会講演抄録集, 35th (Web), 2024年 - インフルエンザウイルス抗原に隠された,保存された構造モチーフを探し出して真似る:抗Idによる分子擬態を用いた新しいユニバーサルワクチン抗原のデザイン
伊藤啓; 佐野芳; 相内章; 鈴木忠樹, 日本抗体学会学術大会プログラム・抄録集(Web), 3rd, 2024年 - エンドヌクレアーゼ阻害剤を用いたA型インフルエンザウイルスPA-Xの性状解析
大石康平; 佐野芳; 長谷川秀樹; 海老原秀喜, 日本ウイルス学会学術集会プログラム・予稿集(Web), 71st, 2024年 - 分泌型IgA抗体の四量体形成分子機構の生化学的・構造生物学的解析
田畑耕史郎; 田畑耕史郎; 福原秀雄; 福原秀雄; 安楽佑樹; 多賀祐喜; 佐々木道仁; 板倉友香里; 佐野芳; 上野朗; 相内章; 後藤希代子; 長谷川秀樹; 前仲勝実; 前仲勝実; 澤洋文; 澤洋文; 大場靖子; 鈴木忠樹, 日本ワクチン学会学術集会プログラム・抄録集, 26th, 2022年 - 分泌型ヒトモノクローナル抗SARS-CoV2IgA抗体の機能および多量体形成効率の解析
上野朗; 上野朗; 佐野芳; 宮本翔; 齊藤慎二; 相内章; 森山彩野; 福士秀悦; 登内奎介; 登内奎介; 逸見拓矢; 逸見拓矢; 高橋宜聖; 竹山春子; 鈴木忠樹, 日本ワクチン学会学術集会プログラム・抄録集, 26th, 2022年 - 経鼻COVID-19組換えタンパク質ワクチンは広域中和能をもつIgA抗体を誘導できる
逸見拓矢; 逸見拓矢; 相内章; 相内章; 橋口隆生; 橋口隆生; 石川青空; 石川青空; 飛梅実; 菅野隆行; 岩田(吉河)奈織子; 飯田俊; 宮本翔; 上野朗; 上野朗; 佐野芳; 田村浩二; 田村浩二; 鈴木亮介; 鈴木亮介; 長谷川秀樹; 鈴木忠樹, 日本ワクチン学会学術集会プログラム・抄録集, 26th, 2022年 - ODN2006をアジュバントとする経鼻COVID-19ワクチンは広域中和能を有するIgA抗体を誘導し,ワクチン関連呼吸器疾患増強のリスクを軽減できる
逸見拓矢; 逸見拓矢; 相内章; 相内章; 橋口隆生; 橋口隆生; 飛梅実; 菅野隆行; 岩田(吉河)奈織子; 飯田俊; 宮本翔; 上野朗; 上野朗; 佐野芳; 齋藤慎二; 志和(須藤)希; 永田典代; 田村浩二; 鈴木亮介; 鈴木亮介; 長谷川秀樹; 鈴木忠樹, 日本ウイルス学会学術集会プログラム・予稿集(Web), 69th, 2022年 - SARS-CoV-2スパイクタンパク質を抗原とする経鼻組換えタンパク質ワクチンによる免疫応答とワクチン効果の評価
逸見拓矢; 逸見拓矢; 相内章; 橋口隆生; 飛梅実; 宮本翔; 菅野隆行; 上野朗; 上野朗; 佐野芳; 田村浩二; 鈴木亮介; 鈴木亮介; 鈴木忠樹, 日本ワクチン学会学術集会プログラム・抄録集, 25th, 2021年 - 経鼻不活化インフルエンザワクチンにより誘導された抗HAストーク抗体の構造情報に基づいた機能予測と中和能の改変
齊藤慎二; 小谷治; 鈴木康司; 相内章; 上野朗; 逸見拓矢; 佐野芳; 田畑耕史郎; 横山勝; 鈴木忠樹; 長谷川秀樹; 佐藤裕徳, 日本ワクチン学会学術集会プログラム・抄録集, 25th, 2021年 - 分泌型モノクローナル抗SARS-CoV-2IgA抗体の機能解析
上野朗; 上野朗; 佐野芳; 宮本翔; 齊藤慎二; 相内章; 森山彩野; 福士秀悦; 登内奎介; 登内奎介; 逸見拓矢; 逸見拓矢; 高橋宜聖; 竹山春子; 鈴木忠樹, 日本ワクチン学会学術集会プログラム・抄録集, 25th, 2021年 - SARS-CoV-2マウス継代ウイルスによる致死モデルの確立
岩田(吉河)奈織子; 志和希; 関塚剛; 佐野芳; 相内章; 逸見拓矢; 逸見拓矢; 片岡紀代; 黒田誠; 長谷川秀樹; 鈴木忠樹; 永田典代, 日本ウイルス学会学術集会プログラム・予稿集(Web), 68th, 2021年 - ポリIg受容体による可変領域非依存的な分泌型IgA抗体の多量体形成促進機構
田畑耕史郎; 田畑耕史郎; 鈴木忠樹; 佐野芳; 齊藤慎二; 相内章; 佐々木道仁; 長谷川秀樹; 大場靖子; 澤洋文; 澤洋文, 日本分子生物学会年会プログラム・要旨集(Web), 44th, 2021年 - 化学発光酵素免疫測定法を用いた高感度新型コロナウイルスSARS-CoV-2抗原測定試薬の開発
今泉 正恭; 西井 友教; 顧 然; 藤本 陽; 宮本 和慶; 鈴木 忠樹; 佐野 芳; 永田 典代; 佐藤 英雄; 小島 哲; 北村 由之; 金子 敦; 八木 慎太郎; 青柳 克己, 医学と薬学, 77, 8, 1201, 1208, 2020年07月
全自動免疫測定装置を用い、核酸検査と同等の高感度でウイルス抗原を定量可能なSARS-CoV2抗原測定試薬(ルミパルスSARS-CoV-2 Ag)を開発し、その性能評価を行った。自家管理検体3例を各々6重測定して得た測定値の変動係数はそれぞれ1.5%、1.6%、1.5%であり、本試薬の検出限界は0.19pg/mL、定量限界は0.60pg/mLであった。リコンビナントSARS-CoV-2 SARS-CoV-2N抗原を検体希釈液、唾液の場合は抗原陰性の唾液で希釈後、希釈直線性を確認した。高値試料1例は1000倍希釈まで、対理論値94〜98%であった。SARS-CoV-2 RNA陽性検体2例は128倍まで、対理論値83〜116%であった。HCoV-229E、HCoV-OC43、HCoV-NL63、HCoV-HKU1のリコンビナントN抗原を用いたところ、交差反応性は確認されなかった。購入したSARS-Cov-2 RNA陽性鼻咽頭スワブ検体30例のSARS-CoV-2抗原測定値とSARS-CoV-2 RNAコピー数は正の相関を示し、相関係数は0.85であった。本試薬は短時間で簡便、かつ多検体を処理できることから、臨床現場における迅速な診断を可能にするとともに、検疫等での利用も期待される。, (株)自然科学社, 日本語 - 重症熱性血小板減少症候群(SFTS)におけるSFTSウイルス感染標的細胞は形質芽球へ分化傾向を示すB細胞である
鈴木 忠樹; 佐藤 由子; 佐野 芳; 片野 晴隆; 中島 典子; 片岡 紀代; 和田 雄治; 高橋 健太; 長谷川 秀樹, 日本病理学会会誌, 109, 1, 471, 471, 2020年03月
(一社)日本病理学会, 日本語 - 経鼻接種型不活化ワクチンと皮下接種型不活化ワクチンにより誘導された抗インフルエンザ抗体の質についての比較解析
佐野芳; 佐野芳; 黒澤信幸; 齊藤慎二; 相内章; 鈴木忠樹; 磯部正治; 長谷川秀樹; 長谷川秀樹; 長谷川秀樹, 日本ワクチン学会学術集会プログラム・抄録集, 23rd, 2019年 - In vitroにおける四量体分泌型IgA抗体形成機構の解明
田畑耕史郎; 田畑耕史郎; 鈴木忠樹; 佐野芳; 齊藤慎二; 相内章; 大場靖子; 長谷川秀樹; 長谷川秀樹; 澤洋文; 澤洋文, 日本分子生物学会年会プログラム・要旨集(Web), 42nd, 2019年 - 経鼻ワクチンにより誘導された抗インフルエンザHAステム抗体のウイルス感染防御機構
佐野芳; 佐野芳; 齊藤慎二; 小谷治; 相内章; VAN RIET Elly; 田畑耕史郎; 高橋宜聖; 横山勝; 佐藤裕徳; 鈴木忠樹; 長谷川秀樹, 日本ワクチン学会学術集会プログラム・抄録集, 22nd, 2018年 - CHO細胞由来ウイルス様粒子を用いたデングウイルスワクチンの有効性評価
藤井信; 藤井信; 鈴木忠樹; 佐高明子; 山口喜之; 佐野芳; 小島朝人; 相内章; 佐藤嗣道; 長谷川秀樹, 日本ワクチン学会学術集会プログラム・抄録集, 22nd, 2018年 - モノクローナル多量体型IgA抗体作製法を用いた分泌型IgA抗体の抗インフルエンザウイルス活性の解析
佐野芳; 佐野芳; 齊藤慎二; 齊藤慎二; 鈴木忠樹; 上野智規; 多賀祐喜; VAN RIET Elly; 相内章; 田畑耕史郎; 藤井信; 高橋宜聖; 後藤希代子; 長谷川秀樹; 長谷川秀樹, 日本ワクチン学会学術集会プログラム・抄録集, 21st, 99, 2017年
日本語 - フィリピンの野生コウモリから検出された新規ヘルペスウイルス遺伝子
佐野芳; 岡崎祥子; 大松勉; 前田健; 久和茂; 谷口怜; 八田勇輝; 三友俊平; 大場真己; 片山幸枝; 佐々悠木子; 古谷哲也; 長井誠; 水谷哲也, 日本獣医学会学術集会講演要旨集, 157th, 415, 415, 2014年08月11日
(公社)日本獣医学会, 日本語
■ 共同研究・競争的資金等の研究課題
- Fc依存性エフェクター機能と広域反応性を併せ持った新規IgA抗体医薬候補の開発
科学研究費助成事業
2025年04月01日 - 2028年03月31日
佐野 芳
日本学術振興会, 若手研究, 国立健康危機管理研究機構, 25K19641 - 抗体レパトア解析を用いた新たなワクチン有効性評価手法の開発
若手研究
2019年04月 - 2021年03月
佐野 芳
本研究では皮下接種インフルエンザワクチンを接種された集団と経鼻不活化全粒子インフルエンザワクチンを接種された集団において、ワクチン接種により誘導された抗体の抗ウイルス活性や遺伝子配列の比較を行った。その結果、異なるワクチンの接種により、誘導される抗体レパトアが遺伝子レベルで異なることが示唆され、また、皮下接種ワクチンと比較して、経鼻ワクチン接種ではIgG状態で複数のウイルス株と反応性を示す交叉反応性抗体クローンが多く誘導されることが明らかとなった。
科学研究費助成事業, 若手研究, 国立感染症研究所, 研究代表者, 競争的資金, 19K17947 - 抗体レパトア解析によるインフルエンザワクチン有効性発現機構の解明
特別研究員奨励費
2018年04月 - 2019年03月
佐野 芳
本年度は、インフルエンザウイルス広域中和抗体の誘導効率がワクチン接種ルートにより異なるという今までに得られている観察結果をもとに、皮下接種ワクチンと経鼻ワクチンにより誘導される抗体の機能および遺伝子的特徴の相違を解析することを目的に、皮下接種ワクチンおよび経鼻ワクチンの接種者から得られた抗体のうち、複数のHA抗原との結合性が認められた、交差結合性クローンについてより詳細な機能解析を行った。まず、交叉結合性クローンがウイルスの細胞への感染性を低下させる能力、ウイルス中和能があるかを検証し、HI(Hemagluttinin Inhibiton)試験により、得られた交差結合性クローンがHA上のレセプター結合サイト(ウイルスがターゲット細胞に侵入する際に必須となる領域)と結合し、ウイルスの細胞への結合・感染を阻止できるか否かを評価した。その結果、皮下接種ワクチンと経鼻ワクチンにより誘導された広域結合性抗体には機能的な差があることが分かった。この機能の差が、抗体をコードする遺伝子の差に由来するものかどうかを評価する為に、抗体の遺伝子配列の解析を行った。ワクチン接種者から単離された形質細胞から得られた全抗体遺伝子をダイレクトシークエンスし、得られた抗体遺伝子配列の遺伝子的特徴(由来遺伝子座や変異率)をIgBLASTにより同定した。また、ワクチンにより誘導された抗体集団をより網羅的に捕捉・解析を行うために、ワクチン接種者の末梢血単核球由来抗体遺伝子の次世代シークエンサーを用いた抗体遺伝子レパトア解析の実験系を立ち上げ、現在解析を進めている途中である。今後は今回の研究により得られた抗体それぞれの遺伝子的特徴とその機能・結合部位との関連が見られるか、さらにはワクチンで誘導された抗体レパトアにどのような特徴が認められるかについて評価していく予定である。
科学研究費助成事業, 特別研究員奨励費, 国立感染症研究所, 研究代表者, 競争的資金, 18J11822
